Louisa Sukkar

More people with diabetes are developing kidney disease, with new risks emerging

Today is world kidney day; a global day of action to raise awareness of the importance of our kidneys to our overall health. The theme this year is Kidney Health for Everyone Everywhere- from prevention to detection and equitable access to care. Crucially, kidney disease can be prevented and progression to end-stage kidney disease can be delayed with appropriate access to basic diagnostics and early treatment

The leading cause of end-stage kidney disease world-wide is type 2 diabetes (T2D). In Australia it is estimated that around 1.7 million people have T2D and in addition to an increased risk of kidney disease are also  at an increased risk of heart disease and strokes.

 A new study in people with diabetes suggests that 1 in 20 people will develop kidney disease each year and that this increases to 1 in 4 each year in people aged 85 years and over. With an ageing population these findings have an important flow on effect on our health system.

George Institute for Global Health researchers found that in addition to the known risk factors for kidney disease such as age, high blood pressure and obesity, having a history of cancer also increased the risk of developing the disease.

Lead author, and  PhD Candidate at the George Institute Dr Louisa Sukkar said that being able to identify people with diabetes who are at increased risk of developing chronic kidney disease (CKD) was a key step to improving health outcomes in this high-risk population.

“While there are factors we don't have control over that increase the likelihood of getting kidney disease - like age - there are also factors we can control which is where we should focus our prevention efforts,” she added.

The study published in Diabetes Care included more than 9,000 Australians aged 45 years and over with diabetes who were followed up for an average of just under six years. Around two thirds of participants were living in a major city, just over a quarter in inner regional areas and less than ten percent in outer regional and remote areas.

The most important factors that were found to increase the risk of kidney disease included:

  • High blood pressure - compared to people who don't have high blood pressure, those who do, had a 1 in 2 chance of getting kidney disease.
  • Obesity - compared to someone of normal weight, those with a BMI over 30 had a 1 in 3 chance of getting kidney disease.

The study found that a history of cancer was also predictive but that further studies were needed to understand why that is.

“We also found that risk increased by over a third for those living in outer regional or remote areas, but this wasn’t related to measures of disadvantage. We think it might be due to poorer access to healthcare and preventative programs in those areas,” said Dr Sukkar.

Factors that lowered the risk of kidney disease included having better kidney function to start with and having a partner.

GH announcement

The George Institute announces 'game changing' investment

On March 10, The George Institute for Global Health announced a $53 million investment to support the commercialisation of the Institute’s world-leading research. The funding from three Australian investors will help address some of the biggest health challenges of our time - heart disease, high blood pressure and diabetes.

Together with key partners and collaborators, policy makers and government officials, Institute staff gathered at the Museum of Contemporary Art in Sydney to share the exciting news and discuss the potential that the funding has to fast track the growth of George Health Enterprises, the Institute’s commercial arm, and George Medicines, its late-stage drug development company.

Professor Robyn Norton AO, Principal Director and Co-Founder of The George Institute for Global Health opened formal proceedings by welcoming guests to the event.

Staph Leavenworth Bakali, President and Chief Executive Officer, George Health, followed, emphasising the importance of the funding to public health,

“one in two of us has a chronic disease. While this is a sobering statistic, what makes it real is that many of us are likely to have people close to us whose lives have changed because they have fallen victim to these conditions.”

Mr Trent Zimmerman MP, Liberal Member for North Sydney (representing the Hon Karen Andrews MP, Minister for Industry, Science and Technology) said that the funding was an “investment in the future of health around the world and an investment into innovation and science in Australia.”

Professor Stephen MacMahon AO, Principal Director and Co-Founder of The George Institute, said the investment was a ‘game changer’ for Australia and for global health, and explained how it will allow The Institute to identify new treatment strategies, develop new drug treatments and innovative treatment approaches, while delivering social and financial returns.